Kate L Lambertsen Selected Research

Kate L Lambertsen Research Topics

Disease

13	Stroke (Strokes) 01/2023 - 10/2008
10	Infarction (Infarctions) 01/2021 - 10/2006
6	Brain Ischemia (Cerebral Ischemia) 01/2023 - 12/2007
6	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 10/2006
5	Ischemic Stroke 01/2021 - 10/2008
4	Ischemia 01/2023 - 10/2006
4	Inflammation (Inflammations) 01/2020 - 07/2014
4	Multiple Sclerosis 01/2020 - 11/2015
3	Neuroinflammatory Diseases 09/2017 - 08/2015
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 08/2015
1	Vascular System Injuries 01/2022
1	Neurosarcoidosis 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Familial Mediterranean Fever (Periodic Disease) 11/2021
1	Transient Ischemic Attack 01/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Cerebral Small Vessel Diseases 01/2020
1	Migraine with Aura (Familial Hemiplegic Migraine) 10/2018
1	Headache (Headaches) 10/2018
1	Migraine Disorders (Migraine) 10/2018
1	Epilepsy (Aura) 10/2018
1	Necrosis 02/2017
1	Demyelinating Diseases (Demyelinating Disease) 01/2017
1	familial type 2 Hemiplegic migraine 02/2016
1	Spinal Cord Injuries (Spinal Cord Injury) 09/2014
1	Cerebral Infarction 07/2014
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 12/2007

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 01/2022 - 08/2015
5	Type I Tumor Necrosis Factor ReceptorsIBA 01/2021 - 01/2016
5	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021 - 01/2016
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 10/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2016
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2016
3	Messenger RNA (mRNA)IBA 01/2016 - 10/2006
2	ChemokinesIBA 01/2022 - 01/2016
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2021 - 01/2020
2	InterleukinsIBA 01/2020 - 02/2017
2	Interleukin-1 (Interleukin 1)IBA 01/2020 - 08/2015
2	Neuroprotective AgentsIBA 02/2012 - 10/2008
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2023
1	3-hydroxycyclopent-1-enecarboxylic acidIBA 01/2023
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Exenatide (Byetta)FDA Link 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	PyrinIBA 11/2021
1	InflammasomesIBA 11/2021
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Tadalafil (Cialis)FDA Link 01/2020
1	Phosphodiesterase 5 InhibitorsIBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	E-SelectinIBA 01/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020
1	N-Methylaspartate (NMDA)IBA 01/2019
1	UCCB01-144IBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	Tat-NR2B9cIBA 01/2019
1	Cilostazol (Pletal)FDA LinkGeneric 10/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Antidepressive Agents (Antidepressants)IBA 01/2018
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018
1	Paroxetine (Paxil)FDA LinkGeneric 01/2018
1	LipopolysaccharidesIBA 09/2017
1	Interleukin-2 (IL2)IBA 02/2017
1	Interleukin-10 (Interleukin 10)IBA 02/2017
1	Interleukin-8 (Interleukin 8)IBA 02/2017
1	Phosphatidylethanolamines (Cephalins)IBA 12/2016
1	Glutamic Acid (Glutamate)FDA Link 02/2016
1	AngiotensinsIBA 01/2016
1	compound 21IBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2016
1	GAP-43 Protein (GAP 43 Protein)IBA 01/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016
1	trkB ReceptorIBA 01/2016
1	InterferonsIBA 11/2015
1	Amyloid beta-PeptidesIBA 08/2015
1	XENP 1595IBA 09/2014
1	Collectins (Collectin)IBA 07/2014
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 07/2014
1	Tat-NPEG4(IETDV)2IBA 02/2012
1	Interleukin-1beta (Interleukin 1 beta)IBA 10/2008
1	diphenyl (biphenyl)IBA 12/2007
1	carbamic acid (ammonium carbamate)IBA 12/2007
1	anandamide (arachidonylethanolamide)IBA 12/2007
1	N-acylethanolaminesIBA 12/2007
1	EstersIBA 12/2007
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 12/2007
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 12/2007
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 12/2007

Therapy/Procedure

3	Therapeutics 01/2020 - 10/2008
1	Intravenous Injections 02/2012